Investigation of hypercalcemia

Clinical Biochemistry

Volumn 45, Issue 12, 2012, Pages 954-963

  Endres, David B ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Corrected calcium; Diagnosis; Hypercalcemia; Hyperparathyroidism; Ionized calcium; Malignancy; Parathyroid hormone; Preanalytical; Total calcium; Vitamin D

Indexed keywords

CALCIUM; CALCIUM ION; CREATININE; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; SERUM ALBUMIN; VITAMIN D;

CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CELL METABOLISM; CHRONIC KIDNEY FAILURE; DIFFERENTIAL DIAGNOSIS; GLYCOLYSIS; GRANULOMATOSIS; HUMAN; HYPERCALCEMIA; HYPOCALCIURIA; IMMOBILIZATION; IMMUNOASSAY; KIDNEY FAILURE; LYMPHOMA; NEOPLASM; OSTEOLYSIS; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; TERTIARY HYPERPARATHYROIDISM; THYROTOXICOSIS; VITAMIN D INTOXICATION;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CALCIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMUNOASSAY; PARATHYROID HORMONE; REFERENCE VALUES; VITAMIN D;

EID: 84863867293     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.04.025     Document Type: Review

References (116)

1. Palmér M., Jakobsson S., Åkerström G., Ljunghall S. Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988, 18:39-46.
2. Christensson T., Hellstrõm K., Wengle B., Alveryd A., Wikland B. Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 1979, 200:131-137.
3. Frolich A. Prevalence of hypercalcemia in normal and in hospital populations. Dan Med Bull 1998, 45:436-439.
4. Endres D.B., Rude R.K. Mineral and bone metabolism. Tietz textbook of clinical chemistry and molecular diagnostics, St Louis, Missouri 2006, 1891-1965. C.A. Burtis, E.R. Ashwood, D.E. Bruns (Eds.).
5. Husdan H., Rapoprt A., Locke S., Oreopoulos D. Effect of venous occlusion of the arm on the concentration of calcium in serum, and methods for its compensation. Clin Chem 1974, 20:529-532.
6. Berry E.M., Gupta M.M., Turner S.J., Burns R.R. Variation in plasma calcium with induced changes in plasma specific gravity, total protein and albumin. Br Med J 1973, 4:640-643.
7. Heath H. Postural and venous stasis - induced changes in total calcium. Mayo Clin Proc 2005, 80:1100-1101.
8. Dixon M., Paterson C.R. Posture and the composition of plasma. Clin Chem 1978, 24:824-826.
9. Fawcett J.K., Wynn V. Effects of posture on plasma volume and some blood constituents. J Clin Pathol 1960, 13:304-310.
10. Eisenberg S. Postural changes in plasma volume in hypoalbuminemia. Arch Int Med 1963, 112:544-549.
11. Eisenberg S., Wolf P.C. Plasma volume after postural change in hypertensive subjects. Arch Int Med 1965, 115:17-22.
12. Boetefür A.K., Müller-Plathe O. Evaluation of a new method for determining total calcium concentration using diluted plasma and an ion-selective electrode. Eur J Clin Chem Clin Biochem 1995, 33:749-754.
13. http://www.westgard.com/biodatabase1.htm.
14. Berry E.M., Gupta M.M., Turner S.J., Burns R.R. Variation in plasma calcium with inducted changes in plasma specific gravity, total protein and albumin. Br Med J 1973, 4:640-643.
15. Ladenson J.H., Lewis J.W., Boyd J.C. Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status. J Clin Endocrinol Metab 1978, 46:986-993.
16. Ladenson J.H., Lewis J.W., McDonald J.M., Slatopolsky E., Boyd J.C. Relationship of free and total calcium in hypercalcemic conditions. J Clin Endocrinol Metab 1979, 48:393-397.
17. Pedersen K.O. An analysis of measured and calculated calcium quantities in serum. Scand J Clin Lab Invest 1978, 38:659-667.
18. Thode J., Juul-Jorgensen B., Bhatia H.M., Kjærulf-Nielsen M., Bartels D., Fogh-Andersen N., Siggaard-Andersen O. Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders. Scand J Clin Lab Invest 1989, 49:217-223.
19. Byrnes M.C., Huynh K., Helmer S.D., Stevens C., Dort J.M., Smith R.S. A comparison of corrected serum calcium levels to ionized calcium among critically ill surgical patients. Am J Surg 2005, 189:310-314.
20. Slomp J., van der Voort P.H.J., Gerritsen R.T., Berk J.A.M., Bakker A.J. Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill. Crit Care Med 2003, 31:1389-1393.
21. Dickerson R.N., Alexander K.H., Minard G., Croce M.A., Brown R.O. Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. J Parenter Enteral Nutr 2004, 28:133-141.
22. Gauci C., Moranne O., Fouqueray B., de la Faille R., Maruani G., Haymann J.-P., et al. Pitfalls in measuring total blood calcium in patients with CKD. J Am Soc Nephrol 2008, 19:1592-1598.
23. Evenepoel P., Bammens B., Clases K., Kuypers D., Meijers B.K.I., Vanrenterghem Y. Measuring total blood calcium displays low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients. Clin J Am Soc Nephrol 2010, 5:2085-2092.
24. Morton A.R., Garland J.S., Holden R.M. Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial 2010, 23:283-289.
25. Gøransson L.G., Skadberg Ø., Bergrem H. Albumin-corrected or ionized calcium in renal failure? What to measure?. Nephrol Dial Transplant 2005, 20:2126-2129.
26. Coulter Beckman Synchron system(s) information sheet for calcium, Fullerton, CA 2010.
27. College of American pathologists interlaboratory proficiency testing. Critical care aqueous blood gas with chemistry, 2011 AQ-C, participant summary, Northfield, IL 2011.
28. CLSI Procedures for the collection of article blood gas specimens; approved guideline. CLSI document H11-A4. Wayne, PA 2004, 4th edition.
29. Fleisher M., Gladstone M., Crystal D., Schwartz M.K. Two whole-blood multi-analyte analyzers evaluated. Clin Chem 1989, 35:1532-1535.
30. Knowles T.P., Mullin R.A., Hunter J.A., Douce F.H. Effects of syringe material, sample storage time, and temperature on blood gases and oxygen saturation in arterialized human blood specimens. Respir Care 2006, 51:732-736.
31. CLSI Ionized calcium determinations: precollection variables, specimen choice, collection and handling; approved guideline. CLSI document C31-A2. Wayne, PA 2001, 2nd edition.
32. Toffaletti J., Thompson T. Effects of blended lithium-zinc heparin on ionized calcium and general chemistry tests. Clin Chem 1995, 41:328-329.
33. Landt M., Hortin G.L., Smith C.H., McClellan A., Scott M.G. Interference in ionized calcium measurements by heparin salts. Clin Chem 1994, 40:565-570.
34. Boink A.B.T.J., Buckley B.M., Christiansen T.F., Covington A.K., Maas A.H.J., Müller-Pathe O, et al. IFCC recommendation on sampling, transport and storage for the determination of the concentration of ionized calcium in whole blood, plasma and serum. J Autom Chem 1991, 13:235-239.
35. Haverstick D.M., Brill L.B., Scott M.G., Bruns D.E. Preanalytical variables in measurement of free (ionized) calcium in lithium heparin-containing blood collection tubes. Clin Chim Acta 2009, 403:102-104.
36. Van Berkel M., Scharnhorst V. Electrolyte-balanced heparin in blood gas syringes can introduce a significant bias in the measurement of positively charged electrolytes. Clin Chem Lab Med 2011, 49:249-252.
37. Dimeski G., Masci P.P., Trabi M., Lavin M.F., de Jersey J. Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?. Clin Chem Lab Med 2010, 48:651-657.
38. Narayanan S. The preanalytic phase: an important component of laboratory medicine. Am J Clin Pathol 2000, 113:429-452.
39. Wang S., McDonnell E.H., Sedor F.A., Toffaletti J.G. pH effects on measurements of ionized calcium and ionized magnesium in blood. Arch Pathol Lab Med 2002, 126:947-950.
40. Seamonds, Towfighi J., Arvan D.A. Determination of ionized calcium in serum by ion-selective electrode. I. Determination of normal values under physiologic conditions, with comments on the effects of food ingestion and hyperventilation. Clin Chem 1972, 18:155-160.
41. Renoe B.W., McDonald J.M., Ladenson J.H. The effects of stasis, with and without exercise, on free calcium, various cations and related parameters. Clin Chim Acta 1980, 103:91-100.
42. Ladenson J.H. Calcium determination in primary hyperparathyroidism. J Bone Miner Res 1991, 6:S33-S41.
43. McLoed M.K., Monchik J.M., Martin H.F. The role of subtle hypercalemia in symptomatic primary hyperparathyroidism. Surgery 1984, 95:667-673.
44. Forster J., Monchik J.M., Martin H.F. A comparative study of serum ultrafiltrable, ionized, and total calcium in the diagnosis of primary hyperparathyroidism in patients with intermittent or no elevation in total calcium. Surgery 1988, 104:1137-1142.
45. Monchik J.M., Gorgun E. Normocalcemic hyperparathyroidism in patients with osteoporosis. Surgery 2004, 136:1242-1246.
46. Boyd J.C., Lewis J.W., Slatopolsky E., Ladenson J.H. Parathyrin measured concurrently with free and total calcium in the differential diagnosis of hypercalcemia. Clin Chem 1981, 27:574-579.
47. Nordenström E., Katzman P., Bergenfelz A. Biochemical diagnosis of primary hyperparathyroidism: analysis of the sensitivity of total and ionized calcium. Clin Biochem 2011, 44:849-852.
48. Bowers G.N., Brassard C., Sena S.F. Measurement of ionized calcium in serum with ion selective electrodes: a mature technology that can meet the daily service needs. Clin Chem 1986, 32:1437-1447.
49. Ijaz A., Mehmood T., Qureshi A.H., Anwar M., Dilawar M., Hussain I., et al. Estimation of ionized calcium, total calcium and albumin corrected calcium for the diagnosis of hypercalcemia of malignancy. J Coll Physicians Surg Pak 2006, 16:49-52.
50. Ferrari P., Singer R., Agarwal A., Hurn A., Townsend M.A., Chubb P. Serum phosphate is an important determinant of corrected serum in end-stage kidney disease. Nephrology 2009, 14:383-388.
51. Clase C.M., Norman G.L., Beecroft M.L., Churchill D.N. Albumin-corrected calcium and ionized calcium in stable hemodialysis patients. Nephrol Dial Transplant 2000, 15:1841-1846.
52. Wandrup J. Critical analytical and clinical aspects of ionized calcium in neonates. Clin Chem 1989, 35:2027-2033.
53. Rodd C., Goodyer P. Hypercalemia of the newborn: etiology, evaluation, and management. Pediatr Nephrol 1999, 13:542-547.
54. Lafferty F.W. Differential diagnosis of hypercalemia. J Bone Miner Res 1991, 6(Suppl. 2):s51-s59.
55. Lee C.-T., Yang C.-C., Lam K.-K., Kung C.-T., Tsai C.-J., Chen H.-C. Hypercalcemia in the emergency department. Am J Med Sci 2006, 331:119-123.
56. Iqbal A.A., Burgess E.H., Gallina D.L., Nanes D.L., Cook C.B. Hypercalcemia in hyperthyroidism: patterns of serum calcium parathyroid hormone and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis. Endocr Pract 2003, 9517-9521.
57. Pellitteri P.K. Evaluation of hypercalcemia in relation to hyperparathyroidism. Otolaryngol Clin North Am 2010, 43:389-397.
58. Jacobs T.P., Bilezikian J.P. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab 2005, 90:6316-6322.
59. Kallas M., Green F., Hewison M., White C., Kline G. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010, 95:3111-3117.
60. Ruda J.M., Hollenbeak C.S., Stack B.C. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005, 132:359-372.
61. Felger E.A., Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am 2010, 43:417-432.
62. Wermers R.A., Khosla S., Atkinson E.J., Hodgson S.F., O'Fallon W.M., Melton L.J. The rise and fall of hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997, 126:443-40.
63. Silverberg E., Lewiecki M., Mosekilde L., Peacock M., Rubin M.R. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94:351-365.
64. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 2009, 94:335-339.
65. Eastell R., Arnold A., Brandi M.L., Brown E.M., D'Amour P., Hanley D.A., et al. Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop. J Clin Endocrinol Metab 2009, 94:340-350.
66. Stewart A.F. Hypercalcemia associated with cancer. N Engl J Med 2005, 352:373-379.
67. Hutchesson A.C., Bundred N.J., Ratcliffe W.A. Survival in hypercalcemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med J 1995, 71:28-31.
68. Saunders B.D., Saunders E.F.H., Gauger P.G. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg 2009, 33:2314-2323.
69. Wermers R.A., Kearns A.E., Jenkins G.D., Melton L.J. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med 2007, 120:911.e9-911.e15.
70. Patel A.M., Goldfarb S. Got calcium? Welcome to the calcium-alkali syndrome. J Am Soc Nephrol 2010, 21:1440-1443.
71. Medarov B.I. Milk-alkali syndrome. Mayo Clin Proc 2009, 84:261-267.
72. Endres D.B., Villanueva R., Sharp C.F., Singer F.R. Measurement of parathyroid hormone. Endocrinol Metab Clin North Am 1989, 18:611-629.
73. Endres D.B., Villanueva R., Sharp C.F., Singer F.R. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 1991, 37:162-168.
74. LePage R., Roy L., Brossard J.-H., Rousseau L., Dorais C., Lazure C., et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assays measurements in uremic samples. Clin Chem 1998, 44:805-809.
75. Wesseling-Perry K., Harkins C., Wang H.-j., Elashoff R., Gales B., Horwitz M.J., et al. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-state kidney disease varies according to bone turnover: a potential role for PTH(7-84). J Clin Endocrinol Metab 2010, 95:2772-2780.
76. Brossard J.H., Lepage R., Cardinal H., Roy L., Rousseau L., Dorais C., et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact assays. Clin Chem 2000, 46:697-703.
77. Gao P., Scheibel S., D'Amour P.D., John M.R., Rao S.D., Schmidt-Gayk H., et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001, 16:605-614.
78. Souberbielle J.-C., Roth H., Fouque D.P. Parathyroid hormone measurement in CKD. Kidney Int 2010, 77:93-100.
79. http://www.roche.com/media/media_releases/med_dia_cv_2011-11-08.htm.
80. Silverburg S.J., Gao P., Brown I., LoGerfo P., Cantor T.L., Bilezikian J.P. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88:4725-4730.
81. Carnevale V., Dionisi S., Nofroni I., Romagnoli E., Paglia F., De Geronimo S., et al. Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem 2004, 50:626-631.
82. Boudou P., Ibrahim F., Cormier C., Chabas A., Sarfati E., Souberbielle J.-C. Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90:6370-6372.
83. Monier-Faugere M.C., Geng Z., Mawad H., Friedler R.M., Gao P., Cantor T.L., et al. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 2001, 60:1460-1468.
84. Coen G., Bonucci E., Ballanti P., Balducci A., Calabria S., Nicolai G.A., et al. PTH 1-84 and PTH '7-84' in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 2002, 40:348-354.
85. Salusky I.B., Goodman W.G., Kuizon B.D., Lavigne J.R., Zahranik R.J., Gales B., et al. Similar predictive values of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 2003, 63:1801-1808.
86. Lehmann G., Stein G., Huller M., Schemer R., Ramakrishnan K., Goodman W.G. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney 2005, 68:1206-1214.
87. D'Amour P., Brossard J.H., Rousseau L., Roy L., Gao P., Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 2003, 49:2037-2044.
88. D'Amour P., Räkel A., Brossard J.-H., Rousseau L., Albert C., Cantor T. Acute regulation of circulating parathyroid hormone molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays. J Clin Endocrinol Metab 2006, 91:283-289.
89. Carter A.B., Howanitz P.J. Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 2003, 127:1424-1442.
90. Chiu B., Sturgeon C., Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg 2006, 141:483-488.
91. Yamashita H., Gao P., Cantor T., Noguchi S., Uchino S., Watanabe S., et al. Comparison of parathyroid hormone levels from intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery 2004, 135:149-156.
92. Moor J.W., Roberts S., Atkin S.L., England R.J.A. Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck 2011, 33:193-196.
93. Looker A.C., Johnson C.L., Lacher D.A., Pfeiffer C.M., Schleicher R.L., Sempos C.T. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011, 59:1-8.
94. IOM (Institute of Medicine) Dietary reference intakes for calcium and vitamin D 2011, The National Academies Press, Washington, DC.
95. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
96. Heany R.P., Dowell M.S., Ca Hale, Bendich A. Calcium absorption varies within the reference interval for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003, 22:142-146.
97. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Dawson-Hughes B. Positive association between 25-hydroxyvitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004, 116:634-639.
98. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., et al. Fall prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. BMJ 2009, b3692.
99. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Intern Med 2009, 169:551-561.
100. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215-3224.
101. Souberbielle J.-C., Cormier C., Kindermans C., Gao P., Cantor T., Forette F., et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001, 86:3086-3090.
102. Souberbielle J.-C., Lawson-Body E., Hammadi B., Sarfati E., Kahan A., Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab 2003, 88:3501-3504.
103. Uhlig K., Berns J.S., Kestenbaum B., Kumar R., Leonard M.B., Martin K.J., et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 2010, 55:773-799.
104. Cantor T., Yang Z., Caraiani N., Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 2006, 52:1771-1776.
105. Glendenning P., Laffer L.L.A., Weber H.K., Musk A.A., Vasikaran S.D. Parathyroid hormone is more stable in EDTA plasma than serum. Clin Chem 2002, 48:766-767.
106. Teal T.K., Wood J.L., Stevens P.E., Lamb E.J. Stability of bio-intact (1-84) parathyroid hormone ex vivo in serum and EDTA plasma from hemodialysis patients. Clin Chem 2004, 50:1713-1714.
107. Stokes F.J., Ivanov P., Bailey L.M., Fraser W.D. The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. Clin Chem 2011, 57:138-140.
108. Kärkkäinen M.U.M., Wiersma J.W., Lamberg-Allardt C.J.E. Postprandial parathyroid hormone response to four calcium-rich foodstuffs. Am J Clin Nutr 1997, 65:1726-1730.
109. Sharma O.P. Vitamin D, calcium, and sarcoidosis. Chest 1996, 109:535-539.
110. Seymour J.F., Gagel R.F. Calcitriol: the major humoral mediator of hypercalemia in Hodgkin's disease and non-Hodgkin's lymphoma. J Am Soc Hematol 1993, 82:1383-1394.
111. Araki T., Holick M.F., Alfonso B.D., Charlap E., Romero C.M., Rizk D., et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J Clin Endocrinol Metab 2011, 96:3603-3608.
112. Singh R.J., Taylor R.L., Reddy S., Grebe S.K.G. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006, 91:355-361.
113. Christensen S.E., Nissen P.H., Vestergaard P., Heickendorff L., Brixen K., Mosekilde L. Discriminative power of three indices of renal calcium excretion for the distinction of familial hypocalciuric hypercalcemia and primary hyperparathyroidism; a follow-up study on methods. Clin Endocrinol 2008, 69:713
114. Christensen S.E., Nissen P.H., Vestergaard P., Heickendroff L., Rejnmark L., Brixen K., et al. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol 2008, 159:719-727.
115. Wermers R.A., Kearns A.E., Jenkins G.D., Melton L.J. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med 2007, 120:911.e9-911.e15.
116. Katzmann J.A., Kyle R.A., Benson J., Larson D.R., Snyder M.R., Lust J.A., et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009, 55:1517-1522.